We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
+35.97%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$55.3M
AUM Growth
-$47.4M
Cap. Flow
+$5
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TBIO
Telesis Bio, Inc. Common Stock
TBIO
+$5

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KYTX icon
1
Kyverna Therapeutics
KYTX
$430M
$24.4M 44.18%
3,255,426
– –
VIGL
2
DELISTED
Vigil Neuroscience
VIGL
$16.9M 30.5%
4,214,498
– –
CADL icon
3
Candel Therapeutics
CADL
$689M
$12M 21.71%
1,935,215
– –
TBIO
4
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$2M 3.61%
546,897
+1
+0% +$5

Similar funds

GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
IV
Industry Ventures San Francisco, California $43.2M AUM 36.57% 1-Year Est. Return
RCM
Riverwood Capital Management Menlo Park, California $43.2M AUM 24% 1-Year Est. Return
EPWM
Essex Private Wealth Management Topsfield, Massachusetts $42.5M AUM 29.61% 1-Year Est. Return
SCMC
Serent Capital Management Company San Francisco, California $44.9M AUM 20.57% 1-Year Est. Return
AS
AM Squared Hong Kong $45.2M AUM 4.27% 1-Year Est. Return
GF
Genesis Fortune Grand Cayman, Cayman Islands $41.8M AUM 76.19% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Northpond Ventures's Q2 2024 Portfolio in Review

As of Q2 2024, Northpond Ventures held 4 positions worth $55.3M, down 46% from $103M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 0%. Northpond Ventures opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Northpond Ventures added most to Telesis Bio, Inc. Common Stock in Q2 2024, an estimated $5 increase.
  • Northpond Ventures's ten largest holdings make up 100% of its $55.3M portfolio in Q2 2024.
  • Northpond Ventures opened 0 new positions and closed 0 in Q2 2024.
  • Northpond Ventures's portfolio value fell 46% quarter-over-quarter to $55.3M.

Based on Northpond Ventures's 13F filing for Q2 2024, filed 14 Aug 2024.